Iloperidone - Atypical Antipsychotic for Schizophrenia

 

Key Data:

Drug (brand/generic)
iloperidone
Company/licensee
Titan Pharmaceuticals /Vanda Pharmaceuticals
Therapy class
Antipsychotic
Product description
Dual-acting dopamine and serotonin receptor antagonist
Current indication
Treatment of schizophrenia and bipolar disorder
Market sector
CNS
Development status
Pre-registration US



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development